publication . Article . Part of book or chapter of book . 2009

In vivo study of HCV in mice with chimeric human livers

Norman M. Kneteman; Christian Toso;
Restricted English
  • Published: 29 Aug 2009
  • Country: Switzerland
Abstract
Estimates of hepatitis C virus infection include 170 million people worldwide, who face increased risk of development of cirrhosis, liver failure, and hepatocellular carcinoma. Standard of care therapy with pegylated interferon and ribavirin is effective in just half of patients, is challenged by substantial treatment-related morbidity, and is prohibitively expensive in most parts of the world. New therapeutics for treatment and prevention are clearly needed. Development of effective therapies has been significantly hampered by difficulties in establishing in vitro and in vivo models of viral replication. This chapter reviews development, validation, and early a...
Persistent Identifiers
Subjects
free text keywords: Animals, Chimera/virology, Disease Models, Animal, Hepacivirus/physiology, Hepatitis C/pathology/virology, Humans, Liver/cytology/pathology/virology, Mice, Reproducibility of Results, Virus Cultivation/methods, Virus Replication/physiology, ddc:617, In vitro, In vivo, Ribavirin, chemistry.chemical_compound, chemistry, Viral replication, Hepatitis C virus, medicine.disease_cause, medicine, Cirrhosis, medicine.disease, Virology, Immunology, Hepatocellular carcinoma, Pegylated interferon, medicine.drug, business.industry, business
Related Organizations
Download fromView all 2 versions
null
http://dx.doi.org/10.1007/978-...
Part of book or chapter of book . 2009
Provider: Crossref
Any information missing or wrong?Report an Issue